Post by
alleyesonme on Sep 23, 2022 10:23pm
Jazz Pharmaceutical BUYOUT.
How much would they pay to protect the 6.7 BILLION$$$ investment........measly little medipharm labs is the only threat to billions of highly profitable revenue through the sale of epidiolex and Sativex....I'm shure it's multiples higher than the present 20million canadian valuation given by the public market of a debt free 20+ mil cash on hand company....just ridiculous....
Comment by
QuantumFlesh on Sep 24, 2022 1:24pm
This post has been removed in accordance with Community Policy
Comment by
subaru1 on Sep 25, 2022 3:11pm
Alleysome, can give more detail about what will happen wednesday. Thanks in advance.
Comment by
subaru1 on Sep 25, 2022 4:07pm
Thank you very much Alleysome, very good information.
Comment by
alleyesonme on Sep 25, 2022 4:22pm
Insurers often only cover the cheaper generic form of a pharmaceutical unless they've negotiated a cheaper than generic price from the brand name...as soon as the generic form is available much of the prescriptions will automatically transfer to the generic by doing of the insurance corps paying for the pharmaceuticals...